174 related articles for article (PubMed ID: 33119062)
1. PTPN11 Mutations in the Ras-MAPK Signaling Pathway Affect Human White Matter Microstructure.
Fattah M; Raman MM; Reiss AL; Green T
Cereb Cortex; 2021 Feb; 31(3):1489-1499. PubMed ID: 33119062
[TBL] [Abstract][Full Text] [Related]
2. PTPN11 Gain-of-Function Mutations Affect the Developing Human Brain, Memory, and Attention.
Johnson EM; Ishak AD; Naylor PE; Stevenson DA; Reiss AL; Green T
Cereb Cortex; 2019 Jul; 29(7):2915-2923. PubMed ID: 30059958
[TBL] [Abstract][Full Text] [Related]
3. Co-occurring SHOC2 and PTPN11 mutations in a patient with severe/complex Noonan syndrome-like phenotype.
Ekvall S; Hagenäs L; Allanson J; Annerén G; Bondeson ML
Am J Med Genet A; 2011 Jun; 155A(6):1217-24. PubMed ID: 21548061
[TBL] [Abstract][Full Text] [Related]
4. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation.
Racine AM; Adluru N; Alexander AL; Christian BT; Okonkwo OC; Oh J; Cleary CA; Birdsill A; Hillmer AT; Murali D; Barnhart TE; Gallagher CL; Carlsson CM; Rowley HA; Dowling NM; Asthana S; Sager MA; Bendlin BB; Johnson SC
Neuroimage Clin; 2014; 4():604-14. PubMed ID: 24936411
[TBL] [Abstract][Full Text] [Related]
5. Analysis of white matter characteristics with tract-based spatial statistics according to diffusion tensor imaging in early Parkinson's disease.
Li XR; Ren YD; Cao B; Huang XL
Neurosci Lett; 2018 May; 675():127-132. PubMed ID: 29199095
[TBL] [Abstract][Full Text] [Related]
6. Research on the Pathogenesis of Cognitive and Neurofunctional Impairments in Patients with Noonan Syndrome: The Role of Rat Sarcoma-Mitogen Activated Protein Kinase Signaling Pathway Gene Disturbances.
Braun-Walicka N; Pluta A; Wolak T; Maj E; Maryniak A; Gos M; Abramowicz A; Landowska A; Obersztyn E; Bal J
Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38136995
[TBL] [Abstract][Full Text] [Related]
7. Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations.
Athota JP; Bhat M; Nampoothiri S; Gowrishankar K; Narayanachar SG; Puttamallesh V; Farooque MO; Shetty S
BMC Med Genet; 2020 Mar; 21(1):50. PubMed ID: 32164556
[TBL] [Abstract][Full Text] [Related]
8. Noonan syndrome, PTPN11 mutations, and brain tumors. A clinical report and review of the literature.
Siegfried A; Cances C; Denuelle M; Loukh N; Tauber M; Cavé H; Delisle MB
Am J Med Genet A; 2017 Apr; 173(4):1061-1065. PubMed ID: 28328117
[TBL] [Abstract][Full Text] [Related]
9. Differences in White Matter Microstructure Among Children With Developmental Coordination Disorder.
Brown-Lum M; Izadi-Najafabadi S; Oberlander TF; Rauscher A; Zwicker JG
JAMA Netw Open; 2020 Mar; 3(3):e201184. PubMed ID: 32186744
[TBL] [Abstract][Full Text] [Related]
10. Deviant white matter structure in adults with attention-deficit/hyperactivity disorder points to aberrant myelination and affects neuropsychological performance.
Onnink AM; Zwiers MP; Hoogman M; Mostert JC; Dammers J; Kan CC; Vasquez AA; Schene AH; Buitelaar J; Franke B
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Dec; 63():14-22. PubMed ID: 25956761
[TBL] [Abstract][Full Text] [Related]
11. Co-occurrence of hypertrophic cardiomyopathy and myeloproliferative disorder in a neonate with Noonan syndrome carrying Thr73Ile mutation in PTPN11.
Yagasaki H; Nakane T; Hasebe Y; Watanabe A; Kise H; Toda T; Koizumi K; Hoshiai M; Sugita K
Am J Med Genet A; 2015 Dec; 167A(12):3144-7. PubMed ID: 26286251
[TBL] [Abstract][Full Text] [Related]
12. White Matter Diffusion of Major Fiber Tracts Implicated in Autism Spectrum Disorder.
Libero LE; Burge WK; Deshpande HD; Pestilli F; Kana RK
Brain Connect; 2016 Nov; 6(9):691-699. PubMed ID: 27555361
[TBL] [Abstract][Full Text] [Related]
13. PTPN11 and KRAS gene analysis in patients with Noonan and Noonan-like syndromes.
Brasil AS; Pereira AC; Wanderley LT; Kim CA; Malaquias AC; Jorge AA; Krieger JE; Bertola DR
Genet Test Mol Biomarkers; 2010 Jun; 14(3):425-32. PubMed ID: 20578946
[TBL] [Abstract][Full Text] [Related]
14. Novel effects of Ras-MAPK pathogenic variants on the developing human brain and their link to gene expression and inhibition abilities.
Rai B; Naylor PE; Siqueiros-Sanchez M; Wintermark M; Raman MM; Jo B; Reiss AL; Green T
Transl Psychiatry; 2023 Jul; 13(1):245. PubMed ID: 37407569
[TBL] [Abstract][Full Text] [Related]
15. Structural insights into Noonan/LEOPARD syndrome-related mutants of protein-tyrosine phosphatase SHP2 (PTPN11).
Qiu W; Wang X; Romanov V; Hutchinson A; Lin A; Ruzanov M; Battaile KP; Pai EF; Neel BG; Chirgadze NY
BMC Struct Biol; 2014 Mar; 14():10. PubMed ID: 24628801
[TBL] [Abstract][Full Text] [Related]
16. SHP2 sails from physiology to pathology.
Tajan M; de Rocca Serra A; Valet P; Edouard T; Yart A
Eur J Med Genet; 2015 Oct; 58(10):509-25. PubMed ID: 26341048
[TBL] [Abstract][Full Text] [Related]
17. Noonan syndrome patients beyond the obvious phenotype: A potential unfavorable metabolic profile.
Noronha RM; Villares SMF; Torres N; Quedas EPS; Homma TK; Albuquerque EVA; Moraes MB; Funari MFA; Bertola DR; Jorge AAL; Malaquias AC
Am J Med Genet A; 2021 Mar; 185(3):774-780. PubMed ID: 33382187
[TBL] [Abstract][Full Text] [Related]
18. Acute lymphoblastic leukemia developing in a patient with Noonan syndrome harboring a PTPN11 germline mutation.
Sakamoto K; Imamura T; Asai D; Goto-Kawashima S; Yoshida H; Fujiki A; Furutani A; Ishida H; Aoki Y; Hosoi H
J Pediatr Hematol Oncol; 2014 Mar; 36(2):e136-9. PubMed ID: 24072241
[TBL] [Abstract][Full Text] [Related]
19. Mutations in PTPN11 could lead to a congenital myasthenic syndrome phenotype: a Noonan syndrome case series.
Pugliese A; Della Marina A; de Paula Estephan E; Zanoteli E; Roos A; Schara-Schmidt U; Hentschel A; Azuma Y; Töpf A; Thompson R; Polavarapu K; Lochmüller H
J Neurol; 2024 Mar; 271(3):1331-1341. PubMed ID: 37923938
[TBL] [Abstract][Full Text] [Related]
20. [Arnold-Chiari malformation in Noonan syndrome and other syndromes of the RAS/MAPK pathway].
Ejarque I; Millán-Salvador JM; Oltra S; Pesudo-Martínez JV; Beneyto M; Pérez-Aytés A
Rev Neurol; 2015 May; 60(9):408-12. PubMed ID: 25912702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
